Skip to main content
. 2017 Jan 30;7:41660. doi: 10.1038/srep41660

Figure 2. Phylogenetic tree analysis of the non-SVR mouse with ASV/DCV.

Figure 2

Human hepatocyte chimeric mice that experienced relapse after LDV/GS-558093 treatment and re-treatment with ASV/DCV. Serum HCV RNA levels (A). N.D., not detected, and S.D., signal detected but at lower quantification levels. Deep sequencing was performed at weeks 10 (point A), 14 (point B) and 26 (point C). The phylogenetic tree was constructed with the top 10 clusters at each time point (A1 to A10 with circles, B1 to B10 with triangles and C1 to C10 with squares) and the top cluster from the minor L31V-Y93H double substitution at week 10 (Am1) (B). *Represents the putative original cluster before ASV/DCV re-treatment that contributed to the L31V-Y93H double substitution after re-treatment.